Spago Nanomedical AB (publ) (STO:SPAGO)
Sweden flag Sweden · Delayed Price · Currency is SEK
0.1145
-0.0015 (-1.29%)
Jul 24, 2026, 3:03 PM CET

Spago Nanomedical AB Balance Sheet

Millions SEK. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
25.9229.6732.4745.2262.152.46
Cash & Short-Term Investments
25.9229.6732.4745.2262.152.46
Cash Growth
-2.46%-8.62%-28.19%-27.19%18.38%84.41%
Accounts Receivable
0.01-0.20.370.050.04
Other Receivables
-0.80.480.990.660.86
Total Trade Receivables
0.010.80.681.360.710.89
Other Current Assets
3.625.475.445.332.431.03
Total Current Assets
29.5535.9438.5951.9165.2454.39
Net Property, Plant & Equipment
0.120.140.610.930.851.08
Other Intangible Assets
----139.86136.16
Long-Term Investments
----0-
Other Long-Term Assets
0.670.610.380.15--
Total Assets
30.3436.6839.5852.99205.95191.62
Accounts Payable
2.783.162.726.394.733.86
Accrued Expenses
2.21.732.714.643.582.55
Other Current Liabilities
0.320.270.440.450.490.41
Total Current Liabilities
5.35.175.8611.488.86.81
Other Long-Term Liabilities
0.840.770.490.19--
Total Long-Term Liabilities
0.840.770.490.19--
Total Liabilities
6.145.946.3511.678.86.81
Common Stock
-6.623.4821.9590.9441.18
Additional Paid-in Capital
-303.4282.1270.56257.15255.37
Accumulated Other Comprehensive Income
--0.38-0.02-0.0388.1184.42
Retained Earnings
--278.89-252.34-251.16-239.05-196.15
Total Common Shareholders' Equity
24.230.7533.2341.32197.16184.81
Shareholders' Equity
24.230.7533.2441.32197.16184.81
Total Liabilities & Equity
30.3436.6839.5852.99205.95191.62
Net Cash (Debt)
25.9229.6732.4745.2262.152.46
Net Cash Growth
-12.63%-8.62%-28.19%-27.19%18.38%84.41%
Net Cash Per Share
0.060.080.090.430.971.31
Book Value
24.230.7533.2341.32197.16184.81
Book Value Per Share
0.050.080.100.393.074.62
Tangible Book Value
24.230.7533.2341.3257.348.65
Tangible Book Value Per Share
0.050.080.100.390.891.22